SL Science Holding Limited (SLBT)
SLBT trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.53
+1.32% on the day
Market cap
$858.0M
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | SLBT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Taiwan |
| IPO year | Not reported by the screener |
| SEC CIK | 0002070534 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | E9 |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-08-14 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-06-18 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-09-24 |
Source: SEC EDGAR submissions feed, 39 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | 0.0% |
| 1 month | -20.9% |
| 3 months | -65.1% |
| Year to date | -85.7% |
| 1 year | -85.4% |
| From 52-week high | -88.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GLUE | Monte Rosa Therapeutics Inc. | $9.89 | -5.99% | $843.7M |
| ODTX | Odyssey Therapeutics Inc. | $17.24 | -5.59% | $828.5M |
| CGEM | Cullinan Therapeutics Inc. | $14.10 | -5.69% | $907.4M |
| MGTX | MeiraGTx Holdings plc | $9.94 | -4.24% | $954.7M |
| DNA | Ginkgo Bioworks Holdings Inc. | $11.76 | -0.25% | $756.6M |
| SANA | Sana Biotechnology Inc. | $2.41 | -8.02% | $721.5M |
| IMTX | Immatics N.V. | $6.83 | -5.27% | $1.0B |
| CADL | Candel Therapeutics Inc. | $9.27 | -5.21% | $709.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier